Login
CanSaRCC
Canadian Sarcoma Research and
Clinical Collaboration
Menu
Overview
MemorialWall
About CanSaRCC
Team
Donate
Clinical Trials
Member Directory
Register
Login
Clinical Trials
(PEAK) A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF CGT9486+SUNITINIB VS SUNITINIB IN SUBJECTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC GASTROINTESTINAL STROMAL TUMORS
Link
:
https://www.clinicaltrials.gov/ct2/show/NCT05208047
Status
:
CLOSED
Population
: GIST
Description
: Sunitinib +/- CGT9486
PI
: A. Razak
Centers Opened
: PMH
Phase
: III
IIST/Pharma
: Pharma